Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis

P Verin, D Easty, A Secchi, G Ciprando, P Partouche, G Nemeth-Wasmer, R Brancato, C Harrisberg, C Estivin-Ebrardt, Douglas Coster, A Apel, M Coroneo, M Knorr, T Carmichael, B Kent-Smith, P Abrantes, A Leonardi, P Cerqueti, G Modorati, M Martinez

    Research output: Contribution to journalArticle

    33 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)691-698
    Number of pages8
    JournalAmerican Journal of Ophthalmology
    Volume131
    Publication statusPublished - 2001

    Cite this

    Verin, P., Easty, D., Secchi, A., Ciprando, G., Partouche, P., Nemeth-Wasmer, G., Brancato, R., Harrisberg, C., Estivin-Ebrardt, C., Coster, D., Apel, A., Coroneo, M., Knorr, M., Carmichael, T., Kent-Smith, B., Abrantes, P., Leonardi, A., Cerqueti, P., Modorati, G., & Martinez, M. (2001). Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis. American Journal of Ophthalmology, 131, 691-698.